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Abstract 
This was a descriptive study which utilized the medical records for the kidney donors and recipients who had 
been followed up in the kidney transplantation programme in Kenyatta National Hospital, Nairobi, Kenya. 
Tissue typing is rarely performed routinely among our patients partially due to cost. It is with this in mind that 
we engaged in extraction of more information from the tissue typing data which have been used in kidney 
transplantation programme in Kenyatta National Hospital, Nairobi Kenya.  The data were extracted from the 
medical records of patients who had undergone tissue typing for renal transplantation and were on follow up at 
Kenyatta National Hospital. The study had been cleared by the Kenyatta National Hospital/University of 
Nairobi Ethics Research Committee, number, P485/9/2013.  
------------------------------------------------------------------------ 
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The medical records had tissue typing done from 2008 and 2013. A total of 269 individuals’ human leucocyte 
antigen typing were utilized. They comprised 134 kidney graft recipients and 135 donors records. The typing 
had been performed using serology for class I and polymerase chain reaction for Class II respectively. The data 
were analysed using Statistical Program for Social Sciences, calculating the frequencies of each individual for  
HLA specificity and expressing it as a percentage of the total population of 269 individuals. For some genes and 
alleles associated with type 1 diabetes (DRB1*03, DRB1*04 and DQB1*02), there were 184/269 (68.4%) of 
individuals who carried genes and alleles. Eighty four (84) individuals had HLA-DRB1*03 allele, 22 had 
DRB1*04 while 78 had DQB1*02. Among 135 kidney graft donors, 39 (28.90%) carried HLA-DRB1*03 and 
14 (10.40%) carried DRB1*04. Among 134 kidney graft recipients, 45 (33.57%) had HLA-DRB1*03 and 13 
(9.70%) had HLA-DRB1*04. Thirty-six (26.87%) had HLA-DQB1*02.  
There is increase in the prevalence of diabetes mellitus among other non-communicable conditions world over. 
Diabetes has both nature and nurture as players for its causation. Genetics which include human leucocyte 
antigens have been liked with diabetes. Among our study population, HLA-DRB1*03, HLA-DRB1*04 and 
HLA-DQB1*02 were prevalent and this may guide surveillance and care for both donors and recipients, as well 
as inform the care of our wider population. 
Keywords: Type 1 diabetes mellitus; Human leucocyte antigens. 
1. Introduction  
1.1 Type 1 diabetes 
Type 1 diabetes mellitus (T1DM) previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or 
"juvenile diabetes" results from the body's failure to produce insulin, and currently requires the person to inject 
insulin or wear an insulin pump. There are multifactorial interactions of the genetic, environmental and 
immunological factors with resultant destruction of the pancreatic beta cells. Individuals with a genetic 
susceptibility have normal beta cell mass at birth but begin to lose beta cells secondary to autoimmune 
destruction that occurs over months to years. The temporal development of type 1 DM is a function of beta cell 
mass. Features of diabetes do not become evident until a majority of beta cells are destroyed (70–80%). At this 
point, residual functional beta cells exist but are insufficient in number to maintain glucose tolerance [1]. 
1.2 Human leucocyte antigens and type 1 diabetes mellitus (T1DM) 
The major genetic determinants of T1DM are polymorphisms of human leucocyte antigens (HLA) class II genes 
encoding DQ and DR. Additional moderate HLA risk haplotypes may help identify the majority of children with 
T1DM before the onset of the disease [2]. Type 1 diabetes mellitus has been associated with Human Leucocyte 
Antigen (HLA)-DRB1*03, -DRB1*04, -DQB1*02 among others [3]. Howson et al found unique diversity of 
the African HLA region among African-American diabetics, which supports a specific and major role for HLA-
DRB1 in HLA-DRB1*03 haplotype-associated T1DM risk  [4]. The pattern of HLA distribution was studied in 
70 Nigerian diabetics by Famuyiwa et al. Comparison of the data with those in other black populations revealed 
that the over-all pattern of HLA distribution in black diabetics is rather disparate and still relatively ill-defined 
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and the pattern of HLA and diabetes association in Nigerian diabetics appeared to be different from that in most 
other racial groups including North American and South African blacks [5].  
2. Materials and method 
Tissue typing is rarely performed routinely among our patients partially due to cost. It is done in routinely 
among the kidney donors and recipients for the purposes of guiding the donors and recipients selection.  
However, the data obtained from the tissue typing have not been utilized in other ways apart from in 
transplantation. It is with this in mind that we engaged in extraction of more information from the tissue typing 
data which have been used in kidney transplantation programme in Kenyatta National Hospital, Nairobi Kenya 
The data were extracted from the medical records of patients who had undergone tissue typing for renal 
transplantation and were on follow up at Kenyatta National Hospital, a teaching and referral hospital in Kenya, 
East Africa. The hospital had been performing living-related kidney graft transplantation from 1980s, but the 
performance had been slow until 2010 when the hospital established a kidney transplant programme in 
collaboration with a partner.  The study had been cleared by the Kenyatta National Hospital/University of 
Nairobi Ethics Research Committee, number, P485/9/2013.  
The medical records had tissue typing done from 2008 and 2013. A total of 269 individuals’ human leucocyte 
antigen typing were got. They comprised 134 kidney graft recipients and 135 donors records were available. 
The donors were living-related to the recipients. The HLA-A, -B, DRB1 and DQB1 alleles groups at both loci 
were extracted. The typing had been performed using serology for class I and polymerase chain reaction for 
Class II respectively. The data were analysed using Statistical Program for Social Sciences, calculating the 
frequencies of each individual for  HLA specificity and expressing it as a percentage of the total population of 
269 individuals.  
3. Results 
Three hundred and three medical records for the kidney transplant donors and recipients were perused for the 
tissue typing laboratory reports. Thirty four were excluded due to incomplete tissue typing reports and 269 
individuals records were used (Figure 1).  
Some genes and alleles associated type 1 diabetes (DRB1*03, DRB1*04 and DQB1*02) 
There were 184/269 (68.4%) of individuals who carried genes and alleles associated with type 1 diabetes 
mellitus. Eighty four (84) individuals who had HLA-DRB1*03 allele, 22 had DRB1*04 while 78 had 
DQB1*02. None of the individual had homozygous HLA-DRB1*03 or HLA-DRB1*04. Two (2) of the 
individuals had homozygous HLA-DQB1*02. Among 135 kidney graft donors, 39 (28.90%) carried HLA-
DRB1*03 and 14 (10.40%) carried DRB1*04. (Table 1). Among 134 kidney graft recipients, 45 (33.57%) had 
HLA-DRB1*03 and 13 (9.70%) had HLA-DRB1*04. Thirty-six (26.87%) had HLA-DQB1*02. Among the 134 
kidney graft recipients, 30 had diabetes mellitus as a documented co-morbidity.  
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Figure 2: Recruitment flowchart 
Table 1: Some genes and alleles associated with type 1 diabetes 
S/No HLA-Gene and 
Allele 
Locus Sex Total 
Male Female 
1 DRB1*03 First 45 22 67  
84 
  Second 14 3 17 
2 DRB1*04 First 12 3 15  
22 
  Second 5 2 7 
3 DQB1*02 First 40 20 60  
78‡ 
  Second 11 9 20 
 Total  127 59 186 184 
 ‡ Two individuals were homozygous  
 
Figure 3: Proportion of the study population who had DRB1*03, DRB1*04 or  DQB1*02 
303 Individuals Medical Records 
(145 donors 158 recipients) 
269 Individuals Medical Records 
(135 donors 134 recipients) 
 34 Medical Records incomplete 
(20 no tissue typing 14 
incomplete tissue typing) 
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Figure 4: Proportion contributed by each of the three genes and alleles 
4. Discussion 
Type 1 diabetes mellitus (T1DM) previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or 
"juvenile diabetes" results from the body's failure to produce insulin, and currently requires the person to inject 
insulin or wear an insulin pump. There are multifactorial interactions of the genetic, environmental and 
immunological factors with resultant destruction of the pancreatic beta cells. Individuals with a genetic 
susceptibility have normal beta cell mass at birth but begin to lose beta cells secondary to autoimmune 
destruction that occurs over months to years. The temporal development of type 1 DM is a function of beta cell 
mass. Features of diabetes do not become evident until a majority of beta cells are destroyed (70–80%). At this 
point, residual functional beta cells exist but are insufficient in number to maintain glucose tolerance [1]. 
Because the trigger is unknown, the autoimmune process is largely undetected until the point of diagnosis. Some 
HLA-genes and alleles have been associated with development of Type 1 diabetes. Some of the HLA genes and 
alleles include HLA-DRB1*03, HLA-DRB1*04 and HLA-DQB1*02.  In our study, more than two-thirds, 
184/269 (68.4%) of individuals carried these genes and alleles in different combinations. (Figure 2). Among 
individuals who had any of the three genes and alleles, HLA-DRB1*03 was in 84, HLA-DQB1*02 was in 78 
and HLA-DRB1*04 was in 22 individuals.( Figure 3).  
There were 84/269 (31.23%) individuals with HLA-DRB1*03 allele. This shows no sex difference in 
contribution to HLA-DRB1*03 allele. None had homozygous state of this allele. Among the 135 donors, 39 
(28.90%) had HLA-DRB1*03. The rest was contributed by the recipients. Among  African American patients 
with Type 1 diabetes J. M. M. Howson et al found that HLA-DRB1*03 confers greatest susceptibility  to T1D 
[6]. Areas in the world where HLA-DRB1*03 allele has been found in high frequency include Pakistan Brahui, 
among rural Asian where Mohyuddin et al detected HLA-DRB1*03 at a frequency of 34.5% [7]. The 
prevalence of diabetes mellitus (DM) and impaired glucose tolerance (IGT) in Parkistan  has been reported as 
glucose intolerance (DM+IGT) was 22.04% in urban and 17.15% in rural areas with major risk factors identified 
were age, positive family history [8]. 
There were 22/269 (8.18%) individuals in whom HLA-DRB1*04 was detected in our study. Among the 135 
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donors, 15 (10.40%) had HLA-DRB1*04. From 134 recipients, 13 (9.70%) had HLA-DRB1*04. The 
distribution of HLA-DRB1*04 in high frequency compares relatively to areas in the world which have reported 
highest prevalence of diabetes. 
In our study, 78/269 (29.00%) of individuals studied had HLA-DQB1*02 allele. Two (2) of the individuals had 
homozygous HLA-DQB1*02. Among 134 recipients, 36 (26.87%) had HLA-DQB1*02.  From 30 recipients 
with diabetes mellitus as a documented co-morbidity, 10 (33.33%) had HLA-DQB1*02. HLA-DQB1*02 allele 
has been reported in frequencies above 25% in several regions of Europe and Asia. It has been reported in 
frequencies above 25% in few regions in America. In Africa, it has been found in frequencies 36.90% in Aka 
Pygmies and Bantu Congolese [9] in Ethiopia among the Oromos and Amharas  at a frequency of 33.70% [10] 
and in Arabic-speaking Moroccans it had been reported at 37.80% allelic frequency [11]. 
5. Conclusion 
There is increase in the prevalence of diabetes mellitus among other non-communicable conditions world over. 
Diabetes has both nature and nurture as players for its causation. Genetics which include human leucocyte 
antigens have been liked with diabetes. Among our study population, HLA-DRB1*03, HLA-DRB1*04 and 
HLA-DQB1*02 were prevalent and this may guide surveillance and care for both donors and recipients, as well 
as inform the care of our wider population. 
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